Rosenzwajg, M., Lorenzon, R., Cacoub, P., Mekinian, A., Daguenel-Nguyen, A., Vicaut, E., . . . Cacciatore, C. (2024, May). Induction of regulatory T cells and efficacy of low-dose interleukin-2 in systemic sclerosis: Interventional open-label phase 1–phase 2a study. RMD Open.
Chicago Style (17th ed.) CitationRosenzwajg, Michelle, et al. "Induction of Regulatory T Cells and Efficacy of Low-dose Interleukin-2 in Systemic Sclerosis: Interventional Open-label Phase 1–phase 2a Study." RMD Open May. 2024.
MLA (9th ed.) CitationRosenzwajg, Michelle, et al. "Induction of Regulatory T Cells and Efficacy of Low-dose Interleukin-2 in Systemic Sclerosis: Interventional Open-label Phase 1–phase 2a Study." RMD Open, May. 2024.
Warning: These citations may not always be 100% accurate.
